Publications by authors named "C J Maguire"

Introduction: Therapeutic advances have allowed more adults aged ≥60 years with acute myeloid leukemia (AML) to receive life-prolonging treatments, with improvement in overall survival. In contrast to other cancers, the onset of AML is often sudden, high-risk treatment decisions must be made quickly, and survival is often compromised due to aging-related conditions (e.g.

View Article and Find Full Text PDF

This practice guideline serves as an update to the Canadian Association of Radiologists' 2013 Technical Standards for Bone Mineral Densitometry Reporting. It aims to align bone mineral density testing and reporting practices in Canada with current clinical best practices, including guidelines from Osteoporosis Canada and the International Society for Clinical Densitometry. Key updates include the endorsement of both FRAX and CAROC tools for evaluating fracture risk, guidance for analyzing male patients and transgender patients, and provision of clinical management guidance of relevance to BMD reporting harmonized with that of Osteoporosis Canada.

View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19) poses significant risks for solid organ transplant recipients, who have atypical but poorly characterized immune responses to infection. We aim to understand the host immunologic and microbial features of COVID-19 in transplant recipients by leveraging a prospective multicenter cohort of 86 transplant recipients age- and sex-matched with 172 non-transplant controls. We find that transplant recipients have higher nasal SARS-CoV-2 viral abundance and impaired viral clearance, and lower anti-spike IgG levels.

View Article and Find Full Text PDF
Article Synopsis
  • Adeno-associated viruses (AAV) are effective for gene therapy, but face challenges like pre-existing immunity in patients and low efficiency in certain cell types.
  • This study uses a metabolic engineering method to enhance the production of extracellular vesicle-enclosed AAV (EV-AAV) by knocking out the PTDSS1 enzyme, resulting in a significantly higher yield and easier purification process.
  • The engineered EV-AAV9 showed improved cell entry and successful gene delivery in mouse brains, indicating that lipid metabolic engineering could enhance gene therapy vectors' effectiveness and development.
View Article and Find Full Text PDF